News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
546,300 Results
Type
Article (41297)
Company Profile (128)
Press Release (504875)
Section
Business (145876)
Career Advice (1994)
Deals (28609)
Drug Delivery (88)
Drug Development (72914)
Employer Resources (144)
FDA (14315)
Job Trends (12151)
News (265129)
Policy (25652)
Tag
Academia (2529)
Alliances (37638)
Alzheimer's disease (1265)
Approvals (14296)
Artificial intelligence (189)
Bankruptcy (257)
Best Places to Work (10140)
Breast cancer (211)
Cancer (1660)
Cardiovascular disease (134)
Career advice (1659)
CAR-T (116)
Cell therapy (334)
Clinical research (58999)
Collaboration (593)
Compensation (240)
COVID-19 (2420)
C-suite (141)
Data (1581)
Diabetes (198)
Diagnostics (5536)
Earnings (54609)
Employer resources (129)
Events (76675)
Executive appointments (469)
FDA (15167)
Funding (602)
Gene therapy (256)
GLP-1 (649)
Government (4071)
Healthcare (16804)
Infectious disease (2529)
Inflammatory bowel disease (112)
Interviews (331)
IPO (14117)
Job creations (2410)
Job search strategy (1430)
Layoffs (357)
Legal (4927)
Lung cancer (257)
Manufacturing (215)
Medical device (11212)
Medtech (11216)
Mergers & acquisitions (14870)
Metabolic disorders (550)
Neuroscience (1668)
NextGen: Class of 2025 (5809)
Non-profit (4157)
Northern California (1784)
Obesity (308)
Opinion (227)
Patents (135)
People (42981)
Phase I (17632)
Phase II (26226)
Phase III (20039)
Pipeline (706)
Postmarket research (2233)
Preclinical (7374)
Radiopharmaceuticals (264)
Rare diseases (339)
Real estate (4206)
Regulatory (18297)
Research institute (2199)
Resumes & cover letters (309)
Series A (116)
Southern California (1546)
Startups (3563)
United States (15476)
Vaccines (591)
Weight loss (220)
Date
Last 7 days (511)
Last 30 days (2161)
Last 365 days (30301)
2025 (3883)
2024 (30946)
2023 (34635)
2022 (44580)
2021 (48306)
2020 (46808)
2019 (40424)
2018 (30631)
2017 (28054)
2016 (26641)
2015 (30975)
2014 (22867)
2013 (18514)
2012 (19656)
2011 (20396)
2010 (18311)
Location
Africa (685)
Asia (32586)
Australia (5788)
California (4044)
Canada (1482)
China (364)
Colorado (189)
Connecticut (212)
Europe (75203)
Florida (603)
Georgia (136)
Illinois (404)
Indiana (202)
Japan (119)
Maryland (632)
Massachusetts (2961)
Michigan (169)
Minnesota (214)
New Jersey (1184)
New York (1191)
North Carolina (716)
Northern California (1784)
Ohio (148)
Pennsylvania (901)
South America (959)
Southern California (1546)
Texas (586)
Utah (112)
Washington State (414)
546,300 Results for "ra capital associates".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Medicenna Therapeutics Announces Closing of CA$20 Million Investment from RA Capital Management
Medicenna Therapeutics Corp. announced the closing of its previously announced CA$20 million investment by RA Capital Management, a multi-stage investment manager based in Boston, MA, by way of a non-brokered private placement.
April 30, 2024
·
5 min read
Biotech Bay
Vaxart Announces $10.0 Million Registered Direct Offering with RA Capital Management
Vaxart, Inc. announced that it has entered into a common stock purchase agreement with RA Capital Management for the sale of 15,384,615 shares of its common stock in a registered direct offering at an offering price of $0.65 per share.
January 16, 2024
·
6 min read
Biotech Beach
Qualigen Therapeutics’ Novel Direct Pan-RAS Inhibitors Presented at American Association of Cancer Research (AACR) 2024 Annual Meeting
Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN) today announces a poster presentation on its preclinical Novel Direct Pan-RAS Inhibitors was presented at the American Association for Cancer Research (AACR) Annual Meeting 2024 held April 5 – 10 in San Diego, California.
April 10, 2024
·
3 min read
Press Releases
Verastem Oncology Outlines 2025 Strategic Priorities and Milestones for Novel Pipeline Targeting RAS/MAPK Pathway-Driven Cancers
January 23, 2025
·
13 min read
Drug Development
Erasca Announces Strategic In-Licensing of RAS-Targeting Franchise
Erasca, Inc. announced it has entered into exclusive license agreements for two preclinical RAS programs—a potential best-in-class pan-RAS molecular glue and a potential first-in-class pan-KRAS inhibitor —and provided a pipeline update.
May 16, 2024
·
10 min read
Press Releases
Anaptys Announces Rosnilimab Achieved Positive Results in RA Phase 2b Trial and Highest Ever Reported CDAI LDA Response Over 6 Months
February 12, 2025
·
13 min read
Press Releases
Revolution Medicines Provides Clinical Updates from its RAS(ON) Inhibitor Portfolio
December 3, 2024
·
13 min read
Press Releases
LAPIX Therapeutics Doses First Patient-In Phase 1b Clinical Trial of LPX-TI641 for Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA)
January 23, 2025
·
3 min read
Press Releases
Erasca Announces Strong Momentum for Naporafenib and RAS Targeting Franchise
October 25, 2024
·
10 min read
Press Releases
Revolution Medicines to Host RAS(ON) Inhibitor Clinical Update Webcast on December 2, 2024
November 28, 2024
·
1 min read
1 of 54,630
Next
